Recruiting
OBSERVATIONAL
NCT07262762
Spartina® (Tirzepatide) Effectiveness and Safety Evaluation
View on ClinicalTrials.gov
Updated Dec 15, 2025
Brief Summary
The goal of this study is to evaluate Effectiveness and safety of Spartina® (Tirzepatide) in male or female participants with obesity and overweight. The main questions which are aimed to be answered: 1. Is Spartina® (Tirzepatide) effective in the treatment of obesity and overweight? 2. Is Spartina® (Tirzepatide) safe in the treatment of obesity and overweight? In this study, there is no comparison group. Participants receive Spartina® (Tirzepatide)
Primary Outcomes
Measure:
Proportion of patients with ≥5% weight loss
TimeFrame:
day 0, 180
Description:
Trial Information
NCT ID
NCT07262762
Status
Recruiting
Study Type
OBSERVATIONAL
Sponsor
Cinnagen
Last Updated
December 15, 2025